Surgery Partners, Inc.
SGRY
$22.80
$0.301.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.47% | -10.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.47% | -10.23% | |||
| Cost of Revenue | 2.69% | -2.65% | |||
| Gross Profit | 20.82% | -30.69% | |||
| SG&A Expenses | 0.28% | 0.00% | |||
| Depreciation & Amortization | 11.02% | 7.08% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.70% | -0.72% | |||
| Operating Income | 35.38% | -48.21% | |||
| Income Before Tax | 14,700.00% | -100.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15,066.67% | 99.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -26.74% | 39.58% | |||
| Net Income | 93.37% | 65.25% | |||
| EBIT | 35.38% | -48.21% | |||
| EBITDA | 28.36% | -39.15% | |||
| EPS Basic | 93.38% | 65.36% | |||
| Normalized Basic EPS | 37.06% | -194.71% | |||
| EPS Diluted | 93.33% | 65.10% | |||
| Normalized Diluted EPS | 37.06% | -194.71% | |||
| Average Basic Shares Outstanding | 0.30% | 0.31% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||